2025 Regular Session • Hawaii Legislature
HB562: Relating To Consumer Protection.
Legislative Summary
Prohibits covered entities in the State from entering into contracts with drug manufacturers that limit the covered entities' use of contract pharmacies. Voids contract provisions for certain drugs if the provisions are based on the maximum allowable cost payment model. Authorizes the attorney general to bring a civil action for violations.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/17/2025
Pending introduction.
House of Representatives
1/21/2025
Introduced and Pass First Reading.
House of Representatives
1/21/2025
Referred to HLT, CPC, JHA, referral sheet 2
House of Representatives
Status Information
Current Status
Introduced(1/17/2025)
Chamber
House of Representatives
Committee
Health(House of Representatives)
Sponsors
Democrat: 14
Primary Sponsor
Cory Chun
Democrat